NCT00709592 Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT Status COMPLETED Phase PHASE2
NCT00703820 Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia Status COMPLETED Phase PHASE3
NCT00697684 Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant Status COMPLETED Phase PHASE1
NCT00689000 Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) Status COMPLETED Phase PHASE1/PHASE2
NCT00678275 Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia Status COMPLETED Phase PHASE3
NCT00674479 INCB018424 in Patients With Advanced Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT00669890 Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML Status TERMINATED Phase PHASE1
NCT00667927 Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission Status COMPLETED Phase PHASE1
NCT00660036 Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT00658814 Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00658411 Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation Status TERMINATED Phase NA
NCT00651781 Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00637052 A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00636922 Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia Status UNKNOWN Phase PHASE1
NCT00629798 Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2
NCT00620321 A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00615784 Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia Status TERMINATED Phase PHASE2
NCT00607997 Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00606216 Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy Status COMPLETED Phase N/A
NCT00602225 Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Status COMPLETED Phase PHASE1/PHASE2